{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T02:14:50Z","timestamp":1773713690274,"version":"3.50.1"},"reference-count":14,"publisher":"The Pediatric Pharmacy Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,16]]},"DOI":"10.5863\/jppt-25-00068","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:31:05Z","timestamp":1773711065000},"source":"Crossref","is-referenced-by-count":0,"title":["Bacterial Resistance Associated With Inhaled Tobramycin for Prevention of Ventilator-Associated Tracheitis in Mechanically Ventilated Neonates and Children Without Cystic Fibrosis: An Observational Pilot Study"],"prefix":"10.5863","author":[{"given":"Avery","family":"Parman","sequence":"first","affiliation":[{"name":"Department of Pharmacy (AP), Oklahoma Children\u2019s Hospital at OU Health, Oklahoma City, OK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (MS), Novant Health Presbyterian Medical Center, Charlotte, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pharmacy: Clinical and Administrative Sciences (JLM, MO, SBN, PNJ), College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misty M.","family":"Oldham","sequence":"additional","affiliation":[{"name":"Department of Pharmacy: Clinical and Administrative Sciences (JLM, MO, SBN, PNJ), College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Neely","sequence":"additional","affiliation":[{"name":"Department of Pharmacy: Clinical and Administrative Sciences (JLM, MO, SBN, PNJ), College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter N.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy: Clinical and Administrative Sciences (JLM, MO, SBN, PNJ), College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"5","key":"JPPT-25-00068-b01","series-title":"Ann Pharmacother","first-page":"430","article-title":"Detectable concentrations with inhaled tobramycin in critically ill infants and children following implementation of a standardized protocol","volume":"59","author":"Johnson","year":"2025","unstructured":"Johnson PN, Chang E, Cormack E, et al. Detectable concentrations with inhaled tobramycin in critically ill infants and children following implementation of a standardized protocol. Ann Pharmacother. 2025;59(5);430\u2013438."},{"issue":"3","key":"JPPT-25-00068-b02","series-title":"J Pediatr Pharmacol Ther","first-page":"332","article-title":"Inhaled tobramycin utilization in critically ill pediatric patients without cystic fibrosis: a Pediatric Pharmacy Association Practice-Based Research Network Survey Study","volume":"30","author":"Johnson","year":"2025","unstructured":"Johnson PN, Ropp DL, Ranallo C, et al. Inhaled tobramycin utilization in critically ill pediatric patients without cystic fibrosis: a Pediatric Pharmacy Association Practice-Based Research Network Survey Study. J Pediatr Pharmacol Ther. 2025;30(3):332\u2013339."},{"key":"JPPT-25-00068-b03","series-title":"Front Pediatr","first-page":"633039","article-title":"Inhaled antibiotics for the prevention of respiratory tract infections in children with a tracheostomy","volume":"9","author":"Jutras","year":"2021","unstructured":"Jutras C, Autmizguine J, Chomtom M, et al. Inhaled antibiotics for the prevention of respiratory tract infections in children with a tracheostomy. Front Pediatr. 2021;9:633039."},{"issue":"4","key":"JPPT-25-00068-b04","series-title":"Pediatr Pulmonol","first-page":"1028","article-title":"Inhaled antibiotics in children with tracheostomy tubes: a descriptive study","volume":"58","author":"Gipsman","year":"2023","unstructured":"Gipsman A, Prero M, Toltzis P, Craven D. Inhaled antibiotics in children with tracheostomy tubes: a descriptive study. Pediatr Pulmonol. 2023;58(4):1028\u20131033."},{"issue":"1","key":"JPPT-25-00068-b05","series-title":"Ann Pharmacother","first-page":"39","article-title":"Inhaled tobramycin in non\u2014cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa","volume":"39","author":"Drobnic","year":"2005","unstructured":"Drobnic ME, Su\u00f1\u00e9 P, Montoro JB, et al. Inhaled tobramycin in non\u2014cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother. 2005;39(1):39\u201344."},{"issue":"2 pt 1","key":"JPPT-25-00068-b06","series-title":"Am J Respir Crit Care Med","first-page":"481","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","unstructured":"Barker AF, Couch L, Fiel SB, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med. 2000;162(2 pt 1):481\u2013485."},{"key":"JPPT-25-00068-b07","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2023","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2023."},{"issue":"5","key":"JPPT-25-00068-b01","series-title":"Ann Pharmacother","first-page":"430","article-title":"Detectable concentrations with inhaled tobramycin in critically ill infants and children following implementation of a standardized protocol","volume":"59","author":"Johnson","year":"2025","unstructured":"Johnson PN, Chang E, Cormack E, et al. Detectable concentrations with inhaled tobramycin in critically ill infants and children following implementation of a standardized protocol. Ann Pharmacother. 2025;59(5);430\u2013438."},{"issue":"3","key":"JPPT-25-00068-b02","series-title":"J Pediatr Pharmacol Ther","first-page":"332","article-title":"Inhaled tobramycin utilization in critically ill pediatric patients without cystic fibrosis: a Pediatric Pharmacy Association Practice-Based Research Network Survey Study","volume":"30","author":"Johnson","year":"2025","unstructured":"Johnson PN, Ropp DL, Ranallo C, et al. Inhaled tobramycin utilization in critically ill pediatric patients without cystic fibrosis: a Pediatric Pharmacy Association Practice-Based Research Network Survey Study. J Pediatr Pharmacol Ther. 2025;30(3):332\u2013339."},{"key":"JPPT-25-00068-b03","series-title":"Front Pediatr","first-page":"633039","article-title":"Inhaled antibiotics for the prevention of respiratory tract infections in children with a tracheostomy","volume":"9","author":"Jutras","year":"2021","unstructured":"Jutras C, Autmizguine J, Chomtom M, et al. Inhaled antibiotics for the prevention of respiratory tract infections in children with a tracheostomy. Front Pediatr. 2021;9:633039."},{"issue":"4","key":"JPPT-25-00068-b04","series-title":"Pediatr Pulmonol","first-page":"1028","article-title":"Inhaled antibiotics in children with tracheostomy tubes: a descriptive study","volume":"58","author":"Gipsman","year":"2023","unstructured":"Gipsman A, Prero M, Toltzis P, Craven D. Inhaled antibiotics in children with tracheostomy tubes: a descriptive study. Pediatr Pulmonol. 2023;58(4):1028\u20131033."},{"issue":"1","key":"JPPT-25-00068-b05","series-title":"Ann Pharmacother","first-page":"39","article-title":"Inhaled tobramycin in non\u2014cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa","volume":"39","author":"Drobnic","year":"2005","unstructured":"Drobnic ME, Su\u00f1\u00e9 P, Montoro JB, et al. Inhaled tobramycin in non\u2014cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother. 2005;39(1):39\u201344."},{"issue":"2 pt 1","key":"JPPT-25-00068-b06","series-title":"Am J Respir Crit Care Med","first-page":"481","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","unstructured":"Barker AF, Couch L, Fiel SB, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med. 2000;162(2 pt 1):481\u2013485."},{"key":"JPPT-25-00068-b07","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2023","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2023."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/aop\/article-10.5863-JPPT-25-00068\/article-10.5863-JPPT-25-00068.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/aop\/article-10.5863-JPPT-25-00068\/article-10.5863-JPPT-25-00068.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/aop\/article-10.5863-JPPT-25-00068\/article-10.5863-JPPT-25-00068.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:31:06Z","timestamp":1773711066000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/aop\/article-10.5863-JPPT-25-00068\/article-10.5863-JPPT-25-00068.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":14,"URL":"https:\/\/doi.org\/10.5863\/jppt-25-00068","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}